VEDOLIZUMAB (VDZ) MAINTENANCE THERAPY FOR ULCERATIVE COLITIS (UC): RESULTS OF GEMINI I, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE 3 TRIAL

(1) University Hospital Gasthuisberg



This item was part of the Novel therapies in IBD session at 20th United European Gastroenterology Week

This item can be cited as: Gut 2012; 61 (Suppl 3) A65